Lista de obras -

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

article

A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants

artículo científico publicado en 2011

A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants

artículo científico publicado en 2011

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

artículo científico publicado en 2014

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

artículo científico publicado en 2007

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants ⬇️

artículo científico publicado el 17 de julio de 2013

Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes

artículo científico

Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes

scientific article published on 15 April 2019

Baseline Assessment of Circulating microRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion

artículo científico publicado en 2020

Blood pressure, insulin, and glycemia in nondiabetic subjects

artículo científico publicado en 1986

Body stature as a risk factor for diabetic sensory neuropathy

artículo científico publicado en 1986

Can non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?

artículo científico publicado en 2017

Development of autoantibodies in the TrialNet Natural History Study

artículo científico publicado en 2011

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

artículo científico publicado en 2016

Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?

artículo científico publicado en 2016

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials.

artículo científico publicado en 2017

ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study

artículo científico publicado en 2016

Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals

scientific article published on 31 January 2020

Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes

artículo científico publicado en 2016

Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.

artículo científico publicado en 2018

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data

artículo científico publicado en 2012

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

artículo científico publicado en 2008

Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).

artículo científico publicado en 2010

HLA-DRB115:01-DQA101:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression

artículo científico publicado en 2016

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives

artículo científico publicado en 2017

Impaired vibratory perception and diabetic foot ulceration

artículo científico publicado en 1986

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

artículo científico publicado en 2009

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

artículo científico publicado en 2007

Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy

artículo científico publicado en 1987

Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood

artículo científico publicado en 2011

One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes

scientific article published on 26 August 2020

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

artículo científico publicado en 2009

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

artículo científico publicado en 2006

Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children

artículo científico publicado en 2019

Prevention of type 1 diabetes: the time has come.

artículo científico publicado en 2008

Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis

artículo científico publicado en 2012

Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes

artículo científico publicado en 2010

Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset

artículo científico publicado en 2009

Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance

artículo científico publicado en 2020

Slowed Metabolic Decline after One Year of Oral Insulin Treatment among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 and TrialNet Oral Insulin Prevention Trials

scientific article published on 21 May 2020

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

scientific article published on October 2015

TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes.

artículo científico publicado en 2017

The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys

artículo científico publicado en 2020

The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms

artículo científico publicado en 2018

The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis

scientific article published on 05 June 2020

The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes

artículo científico publicado en 2019

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study

artículo científico publicado en 2020

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients ⬇️

artículo científico publicado el 1 de julio de 2013

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

artículo científico publicado en 2008

The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies

artículo científico publicado en 2017

The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes

artículo científico publicado en 2012

The association between heart rate and glycemia in adult diabetic subjects ⬇️

artículo científico publicado el 19 de mayo de 1988

The association between symptomatic sensory neuropathy and body stature in diabetic patients

artículo científico publicado en 1988

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months

artículo científico publicado en 2015

The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS).

artículo científico publicado en 2015

The evolution of type 1 diabetes

artículo científico publicado en 2013

The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.

artículo científico publicado en 2017

The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.

artículo científico publicado en 2012

The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants

artículo científico publicado en 2016

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening

artículo científico publicado en 2019

The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes

artículo científico publicado en 2017

The vibratory perception threshold in young diabetic patients: associations with glycemia and puberty

artículo científico publicado en 1985

Transcription Factor 7-Like 2 () Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes

article

Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants

artículo científico publicado en 2009

Use of plaster casts in the management of diabetic neuropathic foot ulcers

scientific article published on 01 March 1986

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes

artículo científico publicado en 2014

Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study

artículo científico publicado en 2011

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies ⬇️

artículo científico publicado el 23 de marzo de 2012

β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis

β cell death and dysfunction during type 1 diabetes development in at-risk individuals

artículo científico publicado en 2015

Lista de obras de

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants

A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants ⬇️

Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes

Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes

Baseline Assessment of Circulating microRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion

Blood pressure, insulin, and glycemia in nondiabetic subjects

Body stature as a risk factor for diabetic sensory neuropathy

Can non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?

Development of autoantibodies in the TrialNet Natural History Study

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials.

ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study

Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals

Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes

Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).

HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives

Impaired vibratory perception and diabetic foot ulceration

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy

Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood

One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children

Prevention of type 1 diabetes: the time has come.

Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis

Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes

Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset

Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance

Slowed Metabolic Decline after One Year of Oral Insulin Treatment among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 and TrialNet Oral Insulin Prevention Trials

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes.

The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys

The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms

The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis

The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients ⬇️

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies

The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes

The association between heart rate and glycemia in adult diabetic subjects ⬇️

The association between symptomatic sensory neuropathy and body stature in diabetic patients

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months

The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS).

The evolution of type 1 diabetes

The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.

The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.

The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening

The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes

The vibratory perception threshold in young diabetic patients: associations with glycemia and puberty

Transcription Factor 7-Like 2 () Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes

Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants

Use of plaster casts in the management of diabetic neuropathic foot ulcers

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes

Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies ⬇️

β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis

β cell death and dysfunction during type 1 diabetes development in at-risk individuals

HLA-DRB115:01-DQA101:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression